by Truveta staff | Mar 22, 2022 | Culture
This month we feature Ryan Ahern, MD MPH, who serves as Truveta’s Chief Medical Officer, and his journey to Truveta. It’s March 2020. Ryan had been living in New York City and held an adjunct faculty position at New York Presbyterian Hospital Weill Cornell Medical...
by Terry Myerson, CEO | Mar 8, 2022 | News
Today in a keynote at ViVE, I unveiled the Truveta platform for the first time with its first public demonstration. While preparing for this keynote, I reflected on how far our team, and our members, have come in the last two years, amidst the backdrop of the COVID-19...
by Truveta Research | Mar 8, 2022 | Research, Research Insights
After looking at the Truveta COVID-19 dashboard, our Research Team was curious about the breakthrough rates for specific disease types and how they compared between fully vaccinated individuals with and without booster shots. The team took the data in the dashboard...
by Truveta Research | Feb 24, 2022 | Research, Research Insights
Rates of myocarditis, pericarditis, and other cardiac conditions have been reported both during the acute phase of Covid-19 infection and up to 12-months post infection. Since this is American Heart Month, we wanted to learn more. So, we asked two key questions of a...
by Truveta staff | Feb 15, 2022 | Culture
I always hoped to be part of a team like this, using new technology to produce and share data-focused health research. When I came across the job listing at Truveta, I felt like I wrote it for myself. I found my dream role where my team can build research and insights...
